AstraZeneca Coronavirus Vaccine

• AstraZeneca reports $275M in sales from vaccine during 1st quarter

  AstraZeneca said its COVID-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April.

  Health

  Apr 30, 2021
  
• Does AstraZeneca’s COVID-19 vaccine cause blood clots? Here’s what we know so far

  Confused? Here's a breakdown of what's happening.

  Canada

  Mar 15, 2021
  
• Advertisement
• AstraZeneca to test coronavirus vaccine response in children for 1st time

  The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.

  Health

  Feb 13, 2021
• Advertisement
• AstraZeneca releases coronavirus vaccine data. Here’s what Canadians should know

  In September, the federal government announced Canada procured 20 million doses of the AstraZeneca-Oxford vaccine.

  Advertisement

  Nov 23, 2020
• AstraZeneca says late-stage trials show coronavirus vaccine ‘highly effective’

  AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90 per cent effective.

  Health

  Nov 23, 2020
• AstraZeneca’s coronavirus vaccine produces strong immune response in older adults

  The data suggests that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.

  Health

  Nov 19, 2020
• Mexico needs 200M coronavirus vaccine shots; officials say doses could start in April

  In partnership with the governments of Mexico and Argentina, AstraZeneca initially plans to produce 150 million doses in early 2021 and eventually make at least 400 million doses for distribution throughout Latin America.

  Health

  Aug 15, 2020